Skip to content
Review

Targeting ferroptosis and oxidative stress crosstalk: a new frontier in stroke neuroprotection

Aug 2026 · Journal of Molecular Histology · Vol 57 · 0 citations · 142 references
Medicine

TL;DR

This review examines the molecular crosstalk between oxidative stress and ferroptosis in ischemia–reperfusion injury and summarizes key pharmacological and natural agents that target these pathways to achieve neuroprotection.

View source

Similar papers

Review Open access Aug 2026

MicroRNA–Ferroptosis–Spinal Cord Injury: A Complex Interplay in Neurodegeneration and Repair

Current evidence on the molecular mechanisms linking miRNAs and ferroptosis in SCI is summarized, highlighting how miRNA-mediated regulation of ferroptosis contributes to neuronal death, glial responses, and impaired regeneration, and discusses emerging therapeutic strategies targeting this axis to promote neuroprotect...

Raju Poongodi, Tao-Hsiang Yang, Kuender D. Yang et al. · 0 citations
Review Open access Aug 2026

Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications

This review focuses on recent findings of perturbed metabolic processes in cancer that create a high iron demand and an altered lipid composition, thereby predisposing cells to ferroptosis and the therapeutic potential of pharmacological agents that can selectively trigger ferroptosis in tumor cells.

Mirjana Macvanin, D. Spasić, S. Gluščević et al. · 0 citations
Review Sep 2026

The redox paradox in neurological disorders: balancing cytoprotection, ferroptosis, and therapeutic targeting.

A contextual framework is built that specifies when HO-1 activation is protective versus detrimental, organised around three converging determinants: cell-type specificity, iron-handling capacity, and disease stage, which is extended to the often-overlooked dimensions of sex, age, and model heterogeneity, and used to i...

Tanvi Premchandani, M. Qutub, Tejaswini Thave et al. · 0 citations
Review Aug 2026

Ferroptosis and Alzheimer's disease: Neuroimmune crosstalk and pharmacological opportunities.

Although available evidence supports an association between ferroptosis-related processes and AD pathobiology, no single marker is sufficient to establish ferroptosis in human AD tissue, which restricts the diagnostic and therapeutic interpretation of ferroptosis in AD.

Yelizaveta A. Marakhovskaya, A. Churov, Mikhail Arbatsky et al. · 0 citations
Review Open access Aug 2026

Mitochondrial dysfunction-driven ferroptosis in cerebral ischemia-reperfusion injury: Mechanisms and therapeutic strategies (Review)

A multidimensional pathological network composed of multiple mitochondrial abnormalities, including mitochondrial reactive oxygen species bursts, Ca2+ overload and disruption of the mitochondrial quality control system, synergistically amplifies lipid peroxidation and drives neuronal ferroptosis across the pathophysiol...

Jian-Hui Li, An-Nan Liu, Wei Gao et al. · 0 citations
Review Open access Sep 2026

Pharmacological Potential of Selenoproteins in the Regulation of Oxidative Stress in Liver Diseases

A more complete understanding of the important role of selenoproteins in regulating liver pathological processes, particularly their antioxidant function, allows them to be considered as promising potential targets for the further development of pharmacotherapeutic strategies for the treatment of chronic liver diseases...

E. G. Varlamova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.